| Cover | Dec. 07, 2020 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Dec. 7, 2020 |
| Entity File Number | 001-37558 |
| Entity Registrant Name | NABRIVA THERAPEUTICS PLC |
| Entity Central Index Key | 0001641640 |
| Entity Tax Identification Number | 00-0000000 |
| Entity Incorporation, State or Country Code | L2 |
| Entity Address, Address Line One | 25-28 North Wall Quay |
| Entity Address, Address Line Two | IFSC |
| Entity Address, City or Town | Dublin 1 |
| Entity Address, Country | IE |
| Entity Address, Postal Zip Code | 00000 |
| City Area Code | 610 |
| Local Phone Number | 816-6640 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Ordinary Shares, nominal value $0.01 per share |
| Trading Symbol | NBRV |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | true |
